Xiaoping Guo
No. 3333 Binsheng Road
Hangzhou, 310052, China
Hangzhou, 310052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Two birds, one BiTE: blinatumomab achieves concurrent B-ALL control and EBV clearance in post-HSCT patients: two cases report.
Journal: BMC pediatrics
Published: November 01, 2025
Rapid Donor-Specific Antibodies Clearance With Short-Course Blinatumomab Prior to Haploidentical HSCT: A Case of Successful Engraftment.
Journal: Pediatric blood & cancer
Published: July 31, 2025
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias.
Journal: Neoplasia (New York, N.Y.)
Published: April 15, 2024
Correction to: Reduced regulatory effects of bone marrow-derived mesenchymal stem cells on activated T lymphocytes and Th1/Th2 cytokine secretion in children with aplastic anemia.
Journal: Clinical and experimental medicine
Published: December 06, 2023
Reduced regulatory effects of bone marrow-derived mesenchymal stem cells on activated T lymphocytes and Th1/Th2 cytokine secretion in children with aplastic anemia.
Journal: Clinical and experimental medicine
Published: September 25, 2023
A scoring system based on fusion genes to predict treatment outcomes of the non-acute promyelocytic leukemia pediatric acute myeloid leukemia.
Journal: Frontiers in medicine
Published: July 13, 2023
Immune microenvironment associated with the severity of Langerhans cell histiocytosis in children.
Journal: Cytokine
Published: May 25, 2023
High percentages of peripheral blood T-cell activation in childhood Hodgkin's lymphoma are associated with inferior outcome.
Journal: Frontiers in medicine
Published: May 28, 2022
Effect of ectopic high expression of transcription factor OCT4 on the "stemness" characteristics of human bone marrow-derived mesenchymal stromal cells.
Journal: Stem cell research & therapy
Published: January 04, 2019
Construction, Expression, and Characterization of a Novel Human-Mouse Chimeric Antibody, Hm3A4: A Potential Therapeutic Agent for B and Myeloid Lineage Leukemias.
Journal: DNA and cell biology
Published: August 11, 2018
KLF4 translation level is associated with differentiation stage of different pediatric leukemias in both cell lines and primary samples.
Journal: Clinical and experimental medicine
Published: January 05, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026